NURS 5315 Final Exam 2 versions Comprehensive Study Guide – Advanced Pathophysiology, Pharmacology, and Clinical Practice Questions with Detailed Answers and Explanations for Nursing Students

NURS 5315 Final Exam 2 versions Comprehensive
Study Guide – Advanced Pathophysiology,
Pharmacology, and Clinical Practice Questions with
Detailed Answers and Explanations for Nursing
Students


Overview
This comprehensive practice set is designed to mirror the scope and complexity of the NURS
5315 Final Exam at UTA. It emphasizes integration of advanced pathophysiology,
pharmacology, and clinical case analysis, requiring students to apply theoretical knowledge to
patient scenarios, interpret lab findings, and select evidence-based interventions. The exam also
incorporates ethical principles and professional practice standards relevant to advanced
nursing roles.

Coverage Areas
 Cardiovascular Disorders – myocardial infarction, arrhythmias, shock syndromes,
hypertension, heart failure.
 Respiratory Disorders – asthma, COPD, ARDS, pneumonia, ventilation-perfusion
mismatch.
 Renal & Endocrine Disorders – chronic kidney disease, diabetic complications, thyroid
dysfunction, adrenal disorders.
 Neurological Disorders – stroke, seizures, neurodegenerative diseases, intracranial
pressure regulation.
 Pharmacology Integration – ACE inhibitors, beta-blockers, insulin, anticoagulants,
glucocorticoids, statins.
 Clinical Case Analysis – prioritization, differential diagnosis, lab interpretation,
treatment planning.
 Ethics & Professional Practice – autonomy, beneficence, justice, confidentiality,
interprofessional collaboration.



Q1. A patient with acute myocardial infarction develops hypotension and cool
extremities. Which mechanism explains cardiogenic shock?
 A. Increased systemic vascular resistance

,  B. Severely reduced cardiac output from ventricular dysfunction
 C. Enhanced preload and contractility
 D. Decreased inflammatory mediators
Cardiogenic shock results from impaired ventricular pumping capacity.
Q2. Which pharmacological agent is most effective in reducing mortality in
patients with systolic heart failure?
 A. Calcium channel blockers
 B. ACE inhibitors
 C. Loop diuretics
 D. Digoxin
ACE inhibitors improve survival by blocking RAAS activation.
Q3. A patient with COPD develops chronic hypoxemia. Which adaptation explains
secondary pulmonary hypertension?
 A. Increased alveolar ventilation
 B. Hypoxic vasoconstriction of pulmonary arteries
 C. Enhanced diffusion capacity
 D. Decreased oxygen consumption
Hypoxemia triggers pulmonary vasoconstriction, raising pulmonary pressures.
Q4. Which pharmacological principle explains why glucocorticoids are effective in
asthma management?
 A. Increased cytokine production
 B. Inhibition of airway inflammatory mediators
 C. Enhanced leukocyte migration
 D. Increased vascular permeability
Glucocorticoids suppress airway inflammation.

,Q5. A patient with cirrhosis develops ascites. Which mechanism explains fluid
accumulation in the peritoneal cavity?
 A. Increased plasma oncotic pressure
 B. Portal hypertension and hypoalbuminemia
 C. Enhanced renal sodium excretion
 D. Decreased capillary hydrostatic pressure
Portal hypertension and low albumin cause ascites.
Q6. Which pharmacological agent is most effective in preventing stroke in atrial
fibrillation patients?
 A. Beta-blockers
 B. Warfarin
 C. ACE inhibitors
 D. Calcium channel blockers
Warfarin prevents clot formation by inhibiting vitamin K–dependent factors.
Q7. A patient with sepsis develops hypotension and tachycardia. Which
mechanism explains septic shock?
 A. Increased vascular resistance
 B. Systemic vasodilation and capillary leak
 C. Enhanced cardiac output
 D. Decreased inflammatory mediators
Sepsis causes vasodilation and fluid leakage.
Q8. Which pharmacological principle explains why beta-blockers reduce mortality
in post-MI patients?
 A. Increased heart rate
 B. Reduced myocardial oxygen demand and arrhythmia risk
 C. Enhanced contractility

,  D. Increased preload
Beta-blockers lower oxygen demand and stabilize rhythm.
Q9. A patient with diabetic ketoacidosis presents with Kussmaul respirations.
Which mechanism explains this compensatory response?
 A. Increased bicarbonate reabsorption
 B. Hyperventilation to reduce CO₂
 C. Decreased hydrogen ion secretion
 D. Increased potassium excretion
Respiratory compensation occurs via hyperventilation.
Q10. Which pharmacological agent is most effective in reducing LDL cholesterol
levels?
 A. Niacin
 B. Statins
 C. Fibrates
 D. Bile acid sequestrants
Statins inhibit cholesterol synthesis in the liver.
Q11. A patient with pneumonia develops hypoxemia. Which mechanism explains
impaired oxygenation?
 A. Increased alveolar ventilation
 B. Alveolar consolidation impairing gas exchange
 C. Enhanced diffusion capacity
 D. Decreased oxygen consumption
Consolidation reduces oxygen diffusion.
Q12. Which pharmacological principle explains why insulin lowers blood glucose
levels?
 A. Increased glucagon secretion